Deprodone propionate

This classification denotes the propionate form of a therapeutic glucocorticoid with the molecular structure C21H28O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, Z380L7N00P chemically known as 11.beta.,17-dihydroxypregna-1,4-diene-3,20-dione, but more commonly known as deprodone, which bears US NIH Compound Identifier 89339. European Medicines Agency schedules Deprodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06982MIG. The term DEPRODONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 2, no. 3, 1988, list 28. ). Most nations, for tariff and trade purposes, schedule deprodone propionate under HS 29372900 and SITC 54153. As of Q4 2014, DEPRODONE PROPIONATE remains US FDA's Preferred Term for this commodity. SMILES: CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)C.